Diversity & Inclusion

Accelerating Global Access

Our company is collaborating with a range of partners to enable access for patients around the world
Dec 13, 2021 8:20 AM ET
Accelerating Global Access infographic

Originally published by Merck

At the outset of our research efforts for COVID-19, our company made clear its commitment to make any vaccine or medicine we develop for this pandemic broadly accessible.

Here’s how we have been working to fulfill that commitment.

Merck & Co., Inc. logo

More from Merck & Co., Inc.

Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care

Career on Purpose (Episode 1): Merck’s Skills-First Program

Here for Good: Merck’s Steadfast Commitment to Health Equity

Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning Center

Women in Science? At Merck, Absolutely

How Merck Scientists Are Driving Next-Generation Cancer Research

Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers

How We Can Strengthen Vaccination Programs and Build Vaccine Confidence Together